Institutional experience on the impact of glucagon-like peptide-1 agonists (GLP-1) on glycemic control and weight loss in patients with type 2 diabetes at the Dubai Diabetes Center, United Arab EmiratesDima Abdelmannan, A. Enrique Caballero, Farya Rahman et al.|Diabetes Research and Clinical Practice|2023Cited by 4
Risk and predictors of severity and mortality in patients with type 2 diabetes and COVID-19 in DubaiFatheya Alawadi, R. A. Bayoumi, Alaaeldin Bashier et al.|World Journal of Diabetes|2023Cited by 3